Department of Health and Social Care
£20m announced to fund vaccines for coronavirus and other infectious diseases
Government has pledged £20 million to develop a new vaccine for coronavirus and other infectious diseases
The Government yesterday pledged £20 million to develop new vaccines to combat the world’s deadliest diseases, amid concerns over the ongoing novel coronavirus outbreak in China.
When visiting the Public Health England’s Porton Down laboratory last week, Health Secretary Matt Hancock announced the UK will ramp up efforts to fund ground-breaking research into vaccines, diagnostics and cures to fight against the threat of future viruses.
The new funding will support work developing new vaccines for epidemics, including their three new programmes to develop vaccines against the novel coronavirus, 2019-nCoV. These projects aim to advance 2019-nCoV vaccine candidates into clinical testing as quickly as possible.
Health Secretary Matt Hancock yesterday said:
Vaccines are our best defense against a host of deadly diseases, including coronavirus. The UK is a hub of world-leading and pioneering research, and it is vital that we lead the way in developing new vaccines to target global threats with scientists from across the world.
The £20 million announced today will help our globally recognised vaccine development capabilities continue to develop new defences against emerging diseases including coronavirus. It’s paramount we invest in vital research about infectious diseases, keeping the UK at the forefront of modern-day science so we can share this knowledge globally.
The £20m in new funding will go to the Coalition for Epidemic Preparedness Innovations (CEPI) – an innovative global partnership between public, private, philanthropic, and civil society organisations launched in Davos in 2017 to develop vaccines to stop future epidemics.
CEPI was originally formed in response to the Ebola epidemic in West Africa.
Dr Richard Hatchett, CEO of CEPI, yesterday said:
CEPI welcomes the UK’s continued support and funding for our vital work, which comes at a crucial moment as the world races to respond to the emergence of a novel coronavirus. The rapid global spread and unique epidemiological characteristics of the virus are deeply concerning.
Our hope is that, with our partners, we can get an investigational vaccine from gene sequencing of the pathogen through to clinical testing in 16 weeks. The earliest stage of clinical trials (Phase I), to establish the safety of investigational vaccines, would take around two to four months.
This is an extremely ambitious timeline – indeed, it would be unprecedented in the of field vaccine development. It is important to remember that even if we are successful - and there can be no guarantee - there will be further challenges to navigate before we can make vaccines more broadly available.
The Government is also in initial stages of talks between NIHR and UKRI regarding plans to run a rapid research call to support the global response to 2019-nCoV.
Latest News from
Department of Health and Social Care
New UK Government Covid testing centre in Dundee16/04/2021 13:20:00
Walk-through coronavirus testing centre opens in Downfield, Dundee.
Surge testing to be deployed in Finchley, Barnet15/04/2021 10:15:00
Additional testing will take place in N3 in Finchley, Barnet, where a confirmed case of the variant first identified in South Africa has been found.
Consultation launched on staff COVID-19 vaccines in care homes with older adult residents14/04/2021 16:05:00
Staff in care homes with older adult residents in England may be required to have a COVID-19 vaccine to protect residents from the virus.
UK moves into next phase of vaccine roll-out as government target hit early14/04/2021 09:05:00
Everybody in cohorts 1 to 9 has been offered a vaccine, with people aged 45 to 49 now invited to book their appointments.
UK health ministers’ statement on JCVI advice (13 April 2021)13/04/2021 14:15:00
A joint statement from the 4 UK health ministers on JCVI advice for phase 2 of the COVID-19 vaccination programme.
Visas extended for thousands of frontline health and care workers09/04/2021 15:22:00
Thousands of crucial frontline health workers and their dependents will be granted free visa extensions, Home Secretary Priti Patel has announced today.
Findings from the latest COVID-19 REACT-1 study published09/04/2021 10:10:10
Findings from the 10th report of REACT-1, one of the country’s largest studies into COVID-19 infections in England, have been published by Imperial College London and Ipsos MORI.
Statement on AstraZeneca Covid-19 vaccine following MHRA update08/04/2021 11:20:00
The Government's statement following updated advice from the UK's medicines regulator.